● I-Pharmacogenetics
-
I-CYP2C9 yomuntu kanye ne-VKORC1 Gene Polymorphism
Le khithi isetshenziswa ekutholweni kwekhwalithi ye-in vitro ye-polymorphism ye-CYP2C9*3 (rs1057910, 1075A>C) kanye ne-VKORC1 (rs9923231, -1639G>A) ku-DNA ye-genomic yamasampuli egazi lonke lomuntu.
-
I-CYP2C19 Gene Polymorphism yomuntu
Le kit isetshenziselwa ukutholwa kwe-in vitro qualitative ye-polymorphism ye-CYP2C19 yofuzo CYP2C19*2 (rs4244285, c.681G>A), CYP2C19*3 (rs4986893, c.636G>A), CYP2C19*20 c1485 (rs168) >T) ku-DNA ye-genomic yamasampula egazi eliphelele lomuntu.
-
I-Leukocyte yomuntu i-Antigen B27 Nucleic Acid
Le kit isetshenziselwa ukutholwa kwekhwalithi ye-DNA kuma-antigen subtypes e-leukocyte yabantu i-HLA-B*2702, HLA-B*2704 kanye ne-HLA-B*2705.
-
I-MTHFR Gene Polymorphic Nucleic Acid
Le khithi isetshenziselwa ukuthola izindawo ezi-2 zokuguqulwa kofuzo lwe-MTHFR.Ikhithi isebenzisa igazi eliphelele lomuntu njengesampula lokuhlola ukuze linikeze ukuhlolwa kwekhwalithi kwesimo soguquko.Ingasiza odokotela ukuthi baklame izinhlelo zokwelashwa ezifanele izici zomuntu ngamunye kusukela ezingeni lamangqamuzana, ukuze kuqinisekiswe impilo yeziguli ngezinga elikhulu kakhulu.
